SACRAL NEUROMODULATION SYSTEM MARKET

INTRODUCTION

The National Health Service pays for the operation known as sacral neuromodulation (NHS). It is used to assist in the treatment of patients with specific bowel and/or bladder disorders.

SNM is an implanted system (a medical device) that works by providing electrical signals to the nerves that regulate your bladder and pelvic floor to help enhance bladder function. The gadget can assist in regaining your bladder's regular function; it resembles a pacemaker (used for the heart).

The gadget, which consists of a cable and a battery tucked away in your buttock, is implanted into the lower section of your spine or back. A basic or advanced evaluation (test phase) and a full system implant are the two steps of SNM (permanent implant).

SACRAL NEUROMODULATION SYSTEM MARKETSIZE AND FORECAST 

TheGlobal sacral neuromodulation system marketaccounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

SACRAL NEUROMODULATION SYSTEM MARKET DYNAMICS

The commercial debut of Axonics F15, a recharge-free implanted neurostimulator (INS) for the treatment of patients with bowel and bladder problems, took place in the US.

Primary cell battery type: INS .Size: 10 cm3Constant current automatically modifies the simulation output during stimulation. Full body MRI compatibility with whole-body 1.5T and 3.0T scanners

InterStim  Micro neurostimulator for sacral neuromodulation (SNM) therapy available in the United States. Cleveland Clinic performed the first patient implant in the nation with the new device.

To enhance bladder and bowel control, sacral neuromodulation transmits electrical impulses to the sacral nerves in the lower back.

Unlike oral drugs that focus on the muscle aspect of bladder control, SNM provides symptom management through direct regulation of the nerve activity, restoring normal bladder-brain communication. 

SACRAL NEUROMODULATION SYSTEM MARKET COMPANY PROFILES

•  Medtronic, Inc. (US)
•  Boston Scientific Corporation (US)
•  St. Jude Medical, Inc. (US)
•  Synapse Biomedical, Inc. (US)
•  Nevro Corporation (US)
•  Neurosigma, Inc. (US)
•  Neuropace, Inc. (US)
•  Neuronetics, Inc. (US)
•  Cyberonics, Inc. (US)

THIS SACRAL NEUROMODULATION SYSTEM MARKET REPORT WILL ANSWER FOLLOWING QUESTIONS

1. What is the average cost perGlobal sacral neuromodulation system right now and how will it change in the next 5-6 years?
2. Average cost to set up aGlobal sacral neuromodulation system  in the US, Europe and China?
3. How many Global sacral neuromodulation system are manufactured per annum globally? Who are the sub-component suppliers in different regions?
4. What is happening in the overall public, globally?
5. Cost breakup of a Global sacral neuromodulation system and key vendor selection criteria
6. Where is the Global sacral neuromodulation system manufactured? What is the average margin per equipment?
7. Market share of Global sacral neuromodulation system manufacturers and their upcoming products
8. The most important planned Global sacral neuromodulation system in next 2 years
9. Details on network of major Global sacral neuromodulation system and pricing plans
10. Cost advantage for OEMs who manufactureGlobal sacral neuromodulation system in-house
11. 5 key predictions for next 5 years inGlobal sacral neuromodulation system market
12. Average B-2-BGlobal sacral neuromodulation system marketprice in all segments
13. Latest trends inGlobal sacral neuromodulation system market, by every market segment
14. The market size (both volume and value) ofGlobal sacral neuromodulation system marketin 2024-2030 and every year in between?
15. Global production breakup ofGlobal sacral neuromodulation system market, by suppliers and their OEM relationship